TITLE

Subverting the adaptive immune resistance mechanism to improve clinical responses to immune checkpoint blockade therapy

AUTHOR(S)
Kim, Young J
PUB. DATE
December 2014
SOURCE
OncoImmunology;Dec2014, Vol. 3 Issue 12, pN.PAG
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The correlation between tumor-infiltrating lymphocyte (TIL)-expression of programmed cell death ligand 1 (PD-L1) and clinical responsiveness to the PD-1 blocking antibody nivolumab implicates adaptive immune evasion mechanisms in cancer. We review our findings that tumor cell PD-L1 expression is induced by interferon γ (IFNγ) producing TILs. We provide a mechanistic rationale for combining IFNγ+T helper type 1 (Th1)-inducing cancer vaccines with PD-1 immune checkpoint blockade.
ACCESSION #
100299022

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics